Chemoprevention of NMU-induced rat mammary carcinoma with the combination of melatonin and 9-cis-retinoic acid.

Journal Article (Journal Article)

In experimental trials using the N-nitroso-N-methylurea (NMU)-induced rat mammary tumor model, a significant decrease in tumor incidence (to 5%) was observed in rats treated with melatonin and 9-cis-retinoic acid (9 cRA) compared to controls (55%). Although 9cRA alone decreased tumor incidence to 26%, this response did not reach statistical significance. Tumor incidence was significantly inhibited to 20% in the animals that received melatonin and 9cRA on alternating days. Latency to tumor onset was prolonged in animals receiving either of the combination treatments compared with controls, and tumor multiplicity was also significantly decreased.

Full Text

Duke Authors

Cited Authors

  • Teplitzky, SR; Kiefer, TL; Cheng, Q; Dwivedi, PD; Moroz, K; Myers, L; Anderson, MB; Collins, A; Dai, J; Yuan, L; Spriggs, LL; Blask, DE; Hill, SM

Published Date

  • July 26, 2001

Published In

Volume / Issue

  • 168 / 2

Start / End Page

  • 155 - 163

PubMed ID

  • 11403920

International Standard Serial Number (ISSN)

  • 0304-3835

Digital Object Identifier (DOI)

  • 10.1016/s0304-3835(01)00548-1


  • eng

Conference Location

  • Ireland